EIX vs KPTI · P/E 7.3, rev $19.32B vs rev $68.5M
Edison International (EIX) versus Karyopharm Therapeutics Inc (KPTI) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
Latest reported EIX revenue for 2025-12-31 was $19.32B. Net income was $4.46B. Revenue was up 9.8% from 2024-12-31 to 2025-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. KPTI currently screens at market cap $205.6M.
Not investment advice. Open the EIX and KPTI stock pages for the full models.
Not investment advice.